Cannabis Legality in the United States

Despite growing legalization at the state level, cannabis remains illegal under federal law in the United States. Today, cannabis policy exists in a complex landscape where individual states determine whether medical or adult-use cannabis is permitted, while federal regulations continue to classify cannabis as a controlled substance. This creates operational, financial, and regulatory challenges for businesses operating in the industry, particularly when it comes to banking, interstate commerce, taxation, and supply chain management. As legalization continues to evolve, understanding the distinction between state and federal cannabis laws remains critical for operators, policymakers, and consumers alike.

Cannabis classification remains one of the most important issues shaping the industry in the United States. While many states have legalized medical or adult-use cannabis, it continues to be classified as a Schedule I substance under federal law. Ongoing discussions around rescheduling and reform could significantly impact research, banking, taxation, and the future of the cannabis industry.

Hemp-derived products occupy one of the most rapidly evolving areas of cannabis regulation in the United States. Under the 2018 Farm Bill, hemp containing less than 0.3% Delta-9 THC by dry weight was federally legalized, opening the door for products such as CBD and other hemp-derived cannabinoids. However, state laws vary significantly, with some states restricting or prohibiting certain products like Delta-8, Delta-10, or intoxicating hemp derivatives. As regulations continue to change, consumers and businesses must navigate a patchwork of federal guidance, state-specific laws, and ongoing policy debates surrounding product safety, labeling, and accessibility.